Smithers Avanza’s Bioanalytical Services Division has completed an expansion of its bioanalytical lab that will accommodate 33% percent more staff to support client needs during the development of large molecule biologic therapies.   “Rising demand for testing from our clients, which include some of the world’s largest biopharmaceutical companies, has resulted in the company more than doubling our scientific and support staff year over year,” said Ira DuBey, executive vice president, Bioanalyt...